Actualités

Actualités
05/12/2023

Oncolytic Virus Research

Oncodesign Services has been working with ViraTherapeutics GmbH, an Austrian company and subsidiary of Boehringer Ingelheim, on their oncolytic viral immunotherapy since 2018.

Medicinal chemistry department | Oncodesign Services
Actualités
31/10/2023

Navigating from molecules to medicines in our chemistry department

Christophe Parsy, Ph.D, MBA, head of the medicinal chemistry team since 2020, presents his team's daily challenges and missions.

Octobre Rose - Oncodesign Services
Actualités
19/10/2023

Breast cancer awareness month

To progress through new treatments, Oncodesign Services supports since many years pharmaceutical companies with breast cancer models such as PDX and CDX models.

27/09/2023

Meet Marie!

Every day, as an invivo research technician, Marie participates in the in vivo studies and tests the effects of a new molecule or a new product. Discover her journey and learn more about working in a lab as a technician.

GHP awards - Oncodesign Services
Actualités
05/07/2023

Oncodesign Services receives global excellence awards

Oncodesign Services is thrilled to announce that we have been awarded 'Best Preclinical Services & Drug Discovery Company 2023 – France!

ImaginAb - Oncodesign Services
Communiqué de Presse
27/06/2023

Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET technology

Oncodesign Services announces the execution of a Preclinical License and Supply Agreement with ImaginAb Inc.

Actualités
22/05/2023

Oncodesign Services and Veritas In Silico enter into business cooperation

Oncodesign Services and Veritas In Silico Inc. announced that they have entered into a Memorandum of Understanding to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting messenger RNA.

Oncodesign Services - Dijon
Actualités
10/05/2023

Dr Eftychia Koumarianou joins as head of pharmaco-imaging and molecular radiotherapy

We announce the appointment of Dr Eftychia Koumarianou as head of its pharmaco-imaging and molecular radiotherapy (MRT) department.

Challenges and perspectives in the preclinical development of therapeutic agents against lung fibrosis
Blog
12/04/2023

Challenges and perspectives in the preclinical development of therapeutic agents against lung fibrosis

In this blog, Pauline Bornert examines the current knowledge about pulmonary fibrosis, and preclinical options available to develop new therapeutic solutions.

Ressource Scientifique
21/02/2023

IBD Case study

Discover an example of a screening cascade developed by Oncodesign Services that led to the identification of preclinical candidates.

Congress
21/02/2023

Oncodesign Services Events in March 2023

Oncodesign is taking part in many events this March. Here is a short selection of where we are travelling over the next few weeks. Learn more here

10/02/2023

The International Day of Women and Girls in Science

We met with women employees of Oncodesign Services to talk their careers and their ambitions for a better valorization of women in Science. Learn more here